BCE (TSE:BCE) PT Raised to C$51.00

BCE (TSE:BCE – Free Report) (NYSE:BCE) had its price target increased by Desjardins from C$48.00 to C$51.00 in a research report released on Friday morning, BayStreet.CA reports. They currently have a hold rating on the stock. BCE has been the subject of a number of other reports. National Bankshares decreased their price target on shares […]

Leave a Reply

Your email address will not be published.

Previous post Eight Capital Cuts Andlauer Healthcare Group (TSE:AND) Price Target to C$51.00
Next post Lexeo Therapeutics (NASDAQ:LXEO) vs. Kiromic BioPharma (NASDAQ:KRBP) Financial Review